ArticleInfection & chemotherapy2025
Risk Factors for Pediatric Intensive Care Unit Admission in Children with Human Metapneumovirus Infections.
Article in Infection & chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Features and Predictors of Severity in Children Hospitalized With Human Metapneumovirus: A Multicenter Italian Study.The Pediatric infectious disease journal · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman metapneumovirus (hMPV) frequently causes respiratory tract infections in children. Although hMPV infections are usually mild and self-limited, they may cause significant morbidity and mortality. However, data on pediatric hospitalizations due to hMPV infection are limited. MATERIALS AND
methodsWe retrospectively analyzed the data of patients aged 18 or younger hospitalized due to hMPV infection at a tertiary hospital between 2014 and 2019.
resultsIn total, 266 pediatric patients were admitted for hMPV infection. The incidence of hospitalizations due to hMPV infections was 6.4 per 1,000 hospitalized children, and the incidence of pediatric intensive care unit (PICU) admissions due to hMPV was 4.1 per 1,000 PICU-admitted children. The median age was 2.2 years (42 days-18.5 years), with 125 patients (47.0%) younger than two years old. Twenty-eight patients (10.5%) were treated in the PICU, and five of them (17.9%) died. The proportion of patients with underlying diseases was higher in the PICU group than in the general ward group (85.7%
conclusionhMPV can cause severe infections that lead to PICU admission, particularly in patients with underlying conditions and fatal outcomes. Further data on hMPV infection in children admitted to the PICU and the overall disease burden in society are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.